Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan I Silverberg

Showing results (471-480 of 545) with videos related to

Pageof 55
Sort By:
Dermatitis : Contact, Atopic, Occupational, Drug|December 4, 2020
Patch Testing of Mercaptobenzothiazole and Mercapto Mix: The North American Contact Dermatitis Group Experience, 1994-2016Erin M Warshaw, Rachit Gupta, Joel G DeKoven, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|July 9, 2021
Patch Testing With Tocopherol and Tocopherol Acetate: The North American Contact Dermatitis Group Experience, 2001 to 2016Erin M Warshaw, Jenna L Ruggiero, Joel G DeKoven, et al.
Journal of the American Academy of Dermatology|October 11, 2020
Contact dermatitis to personal care products is increasing (but different!) in males and females: North American Contact Dermatitis Group data, 1996-2016Erin M Warshaw, Jamie P Schlarbaum, Jonathan I Silverberg, et al.
Dermatology and Therapy|February 14, 2025
Lebrikizumab vs Other Systemic Monotherapies for Moderate-to-Severe Atopic Dermatitis: Network Meta-analysis of EfficacyJonathan I Silverberg, Thomas Bieber, Amy S Paller, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|July 31, 2023
Patch Testing to Paraphenylenediamine: The North American Contact Dermatitis Group Experience (1994-2018)Erin M Warshaw, Malina Yamashita Peterson, Amber R Atwater, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|June 21, 2021
Contact Dermatitis Associated With Hair Care Products: A Retrospective Analysis of the North American Contact Dermatitis Group Data, 2001-2016Erin M Warshaw, Jenna L Ruggiero, Joel G DeKoven, et al.
Journal of the American Academy of Dermatology|August 22, 2020
Scalp involvement in patients referred for patch testing: Retrospective cross-sectional analysis of North American Contact Dermatitis Group data, 1996 to 2016Erin M Warshaw, Sara A Kullberg, Joel G DeKoven, et al.
JAMA Dermatology|July 17, 2024
Cendakimab in Patients With Moderate to Severe Atopic Dermatitis: A Randomized Clinical TrialAndrew Blauvelt, Emma Guttman-Yassky, Charles Lynde, et al.
Journal of the American Academy of Dermatology|May 22, 2024
Tapinarof cream 1% once daily: Significant efficacy in the treatment of moderate to severe atopic dermatitis in adults and children down to 2 years of age in the pivotal phase 3 ADORING trialsJonathan I Silverberg, Lawrence F Eichenfield, Adelaide A Hebert, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|January 14, 2021
Patch Testing With Carmine 2.5% in Petrolatum by the North American Contact Dermatitis Group, 2011-2012Erin M Warshaw, Lindsey M Voller, Joel G DeKoven, et al.
Pageof 55

Showing results (471-480 of 545) with videos related to

Sort By:
Pageof 55
Dermatitis : Contact, Atopic, Occupational, Drug|December 4, 2020
Patch Testing of Mercaptobenzothiazole and Mercapto Mix: The North American Contact Dermatitis Group Experience, 1994-2016Erin M Warshaw, Rachit Gupta, Joel G DeKoven, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|July 9, 2021
Patch Testing With Tocopherol and Tocopherol Acetate: The North American Contact Dermatitis Group Experience, 2001 to 2016Erin M Warshaw, Jenna L Ruggiero, Joel G DeKoven, et al.
Journal of the American Academy of Dermatology|October 11, 2020
Contact dermatitis to personal care products is increasing (but different!) in males and females: North American Contact Dermatitis Group data, 1996-2016Erin M Warshaw, Jamie P Schlarbaum, Jonathan I Silverberg, et al.
Dermatology and Therapy|February 14, 2025
Lebrikizumab vs Other Systemic Monotherapies for Moderate-to-Severe Atopic Dermatitis: Network Meta-analysis of EfficacyJonathan I Silverberg, Thomas Bieber, Amy S Paller, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|July 31, 2023
Patch Testing to Paraphenylenediamine: The North American Contact Dermatitis Group Experience (1994-2018)Erin M Warshaw, Malina Yamashita Peterson, Amber R Atwater, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|June 21, 2021
Contact Dermatitis Associated With Hair Care Products: A Retrospective Analysis of the North American Contact Dermatitis Group Data, 2001-2016Erin M Warshaw, Jenna L Ruggiero, Joel G DeKoven, et al.
Journal of the American Academy of Dermatology|August 22, 2020
Scalp involvement in patients referred for patch testing: Retrospective cross-sectional analysis of North American Contact Dermatitis Group data, 1996 to 2016Erin M Warshaw, Sara A Kullberg, Joel G DeKoven, et al.
JAMA Dermatology|July 17, 2024
Cendakimab in Patients With Moderate to Severe Atopic Dermatitis: A Randomized Clinical TrialAndrew Blauvelt, Emma Guttman-Yassky, Charles Lynde, et al.
Journal of the American Academy of Dermatology|May 22, 2024
Tapinarof cream 1% once daily: Significant efficacy in the treatment of moderate to severe atopic dermatitis in adults and children down to 2 years of age in the pivotal phase 3 ADORING trialsJonathan I Silverberg, Lawrence F Eichenfield, Adelaide A Hebert, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|January 14, 2021
Patch Testing With Carmine 2.5% in Petrolatum by the North American Contact Dermatitis Group, 2011-2012Erin M Warshaw, Lindsey M Voller, Joel G DeKoven, et al.
Pageof 55